Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth Expands US Insurance Coverage for Prostate Cancer Test

NEW YORK (GenomeWeb News) – MDxHealth said today that it has signed up two additional US health insurance providers to cover its prostate cancer test.

Under the agreements, the company's ConfirmMDx for Prostate Cancer test will be covered by HealthSmart, a preferred provider organization network, and Fortified Provider Network.

The company said that with the new agreements more than 135 million people in the US can access the test through their insurance.

HealthSmart is a group of managed healthcare companies that offers products and services to employers, payors, and third-party administrators, and it owns several PPO networks. FPN is a national direct-contracted preferred provider network of more than 200 payor clients and members.

In October, MDxHealth signed up FedMed and America's Choice Provider Network to cover the prostate cancer test.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.